spironolactone has been researched along with danazol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rosazza, JP; Smith, RV | 1 |
| Biffignandi, P; Massucchetti, C; Molinatti, GM | 1 |
| Curole, DN; Dickey, RP; Taylor, SN | 1 |
| Johnson, SR | 1 |
| Feyles, V; Gianetto-Berruti, A | 1 |
| Hirvonen, J; Kangas, H; Kortejärvi, H; Lehto, P; Liimatainen, A; Ojala, K; Peltonen, L; Tanninen, VP | 1 |
5 review(s) available for spironolactone and danazol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Microbial models for drug metabolism.
Topics: Acronine; Animals; Aporphines; Bacteria; Biotransformation; Cannabinoids; Chemical Phenomena; Chemistry; Cytochrome P-450 Enzyme System; Danazol; Daunorubicin; Ellipticines; Fungi; Indans; Mammals; Models, Biological; Oxidation-Reduction; Oxygenases; Papaverine; Pharmaceutical Preparations; Prostaglandins; Species Specificity; Spironolactone; Thiazoles; Yeasts | 1979 |
[Intracellular and extracellular proteins binding androgenic hormones. Biochemical properties and clinical significance].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Androgen-Binding Protein; Androgen-Insensitivity Syndrome; Breast Neoplasms; Carrier Proteins; Danazol; Disorders of Sex Development; Female; Humans; Hyperthyroidism; Infertility, Male; Liver Cirrhosis; Male; Minoxidil; Receptors, Androgen; Sex Hormone-Binding Globulin; Spironolactone | 1983 |
Premenstrual syndrome therapy.
Topics: Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Bromocriptine; Contraceptives, Oral, Combined; Danazol; Evidence-Based Medicine; Exercise Therapy; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Gonadotropin-Releasing Hormone; Humans; Linoleic Acids; Oenothera biennis; Ovariectomy; Plant Oils; Premenstrual Syndrome; Progesterone; Progestins; Pyridoxine; Selective Serotonin Reuptake Inhibitors; Spironolactone; Vitamin E | 1998 |
Premenstrual syndrome.
Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Contraceptives, Oral; Danazol; Diagnosis, Differential; Diet; Diuretics; Estrogen Antagonists; Exercise; Female; Gonadotropin-Releasing Hormone; Humans; Life Style; Mineralocorticoid Receptor Antagonists; Minerals; Plant Preparations; Premenstrual Syndrome; Progestins; Prospective Studies; Randomized Controlled Trials as Topic; Research; Selective Serotonin Reuptake Inhibitors; Spironolactone; Vitamins | 2002 |
9 other study(ies) available for spironolactone and danazol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone.
Topics: Adult; Age Factors; Body Weight; Danazol; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Humans; Pelvic Neoplasms; Pregnadienes; Progesterone; Radioimmunoassay; Spironolactone | 1984 |
Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs.
Topics: Absorption; Animals; Biopharmaceutics; Body Fluids; Computer Simulation; Danazol; Diuretics; Dogs; Estrogen Antagonists; Fasting; Female; Intestines; Male; Micelles; Pharmaceutical Preparations; Polysorbates; Sodium Dodecyl Sulfate; Solubility; Spironolactone; Surface-Active Agents | 2011 |